Human respiratory syncytial virus virions are colorized blue in this electron microscope image. The U.S. approved the first vaccine for RSV on Wednesday, allowing the sale of shots to protect older adults from a respiratory virus that’s most notorious for attacking babies but endangers their grandparents too. The move sets the stage for adults 60 and older to get vaccinated …
